Inventor · disambiguated record
Philip Wickens
Also filed as: WICKENS PHILIP · WICKENS PHILIP L
14 granted patents·6 pending applications·49 citations·filing 1993–2011
89Inventor score
Files withBAYER PHARMACEUTICALS CORP8LOWE DEREK B4MAGNUSON STEVEN2BAYER HEALTHCARE AG1BAYER HEALTHCARE LLC1
Top patents by PatentIndex Score
20 records- 0183US7358386B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Apr 15, 2008·5 cites·2 claims
- 0282US6828335B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·15 cites·102 claims
- 0380US7517878B2Heteroarylaminopyrazole derivatives useful for the treatment of diabetesBAYER PHARAMCEUTICALS CORP·Filed 2005·Granted Apr 14, 2009·8 cites·9 claims
- 0476US7112597B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 26, 2006·7 cites·73 claims
- 0569US8138336B2Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinaseMAGNUSON STEVEN·Filed 2008·Granted Mar 20, 2012·2 cites·15 claims
- 0667US8541618B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2011·Granted Sep 24, 2013·1 cites·44 claims
- 0765US8796253B2Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBOYER STEPHEN·Filed 2008·Granted Aug 5, 2014·1 cites·20 claims
- 0863US7265144B2Anilinopyrazole derivatives useful for the treatment of diabetesBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Sep 4, 2007·2 cites·40 claims
- 0959US5410033ADeoxygenation of cis vicinal diols to make didehydro dideoxy nucleosidies and synthetic intermediatesTEROCHEM LAB LTD·Filed 1993·Granted Apr 25, 1995·8 cites·28 claims
- 1059US2011065129A1Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2009·Application pending·0 cites
- 1159US2009047687A1Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of PreparationLOWE DEREK B·Filed 2008·Application pending·0 cites
- 1253US2008064734A1Anilinopyrazole derivatives useful for the treatment of diabetesBAYER PHARMACEUTICALS CORP·Filed 2007·Application pending·0 cites
- 1352US8552203B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2011·Granted Oct 8, 2013·0 cites·11 claims
- 1451US7714004B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2003·Granted May 11, 2010·0 cites·34 claims
- 1546US8338594B2Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinaseMAGNUSON STEVEN·Filed 2006·Granted Dec 25, 2012·0 cites·14 claims
- 1643US7906653B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER HEALTHCARE LLC·Filed 2010·Granted Mar 15, 2011·0 cites·29 claims
- 1743US7476742B2Indane acetic acid derivatives and their use as pharmaceutical agentsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jan 13, 2009·0 cites·13 claims
- 1842US2009023753A11,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic AgentsBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 1942US2008293696A12-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic AgentsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 2040US2005014805A1Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesityFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Wickens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →